ArticleMultiple sclerosis journal - experimental, translational and clinical

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial.

Gary Cutter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.